Back to search results

Videoscope for Periodontal Regeneration

This study is looking at whether using a videoscope during minimally invasive surgery for chronic periodontitis (gum disease) can improve treatment outcomes. Chronic periodontitis causes loss of the supporting tissues around your teeth. The study compares three approaches: videoscope-assisted periodontal regeneration, conventional periodontal regeneration, and guided tissue regeneration surgery. Researchers want to see if better visualization of the surgical area with a videoscope helps remove disease-causing factors more effectively. You may be eligible if you are between 18 and 70 years old, generally healthy, and have at least one tooth with a specific type of bone defect and deep gum pockets. The study will measure improvements in gum health, such as clinical attachment level, probing depth, and gum recession, after 6 months. The current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 50 participants. It compares different surgical techniques for treating chronic periodontitis.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your gum health will be measured at 6 months after the procedure to see the results of the treatment.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05275192

Utilization of a Videoscope in Periodontal Regeneration

Active, Not Recruiting
NAAges 18–70InterventionalTreatment
University of Illinois at Chicago
~50 participants
Updated 2026-08-17 on ClinicalTrials.gov
What's tested:Videoscope-assisted periodontal regeneration minimally invasive surgeryPeriodontal regeneration minimally invasive surgeryGuided tissue regeneration surgery

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Clinical Attachment Level
Measured over 6 months
+9 more outcomes measured

Conditions

Chronic Periodontitis

Explore related trials

Periodontitis

Where it's being run

1 sites across 1 states
Illinois1

Study leadership

  • Salvador Nares, DDS, PhD · PRINCIPAL_INVESTIGATOR · University of Illinois at Chicago

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

• Individual must be between the age of 18 and 70 years of age
ASA I or II systemically healthy subjects
Individuals presenting with at least 1 single or multirooted tooth with residual, isolated, interproximal bony defect with probing depths (PD) ≥ 6 mm, clinical attachment loss (CAL) ≥ 6mm, bleeding upon probing (BOP), and ≥ 2mm width of attached gingiva (WAG)
Radiographic evidence of interproximal alveolar bone loss, on existing (\< 2 years old) dental radiographs of diagnostic quality taken at the COD
Vital tooth or previous root canal therapy with no signs/symptoms of pathology
Individuals with plaque scores ≤ 20%
English speaking subjects (Individual must be willing to follow all the study requirements and participate in the study procedures in its entirety and read, understand the informed consent form)

Exclusion

Individuals not referred from the Predoctoral Periodontics Student Clinics
Uncontrolled systemic disorders such as hypertension, heart disease, bleeding disorders, metabolic bone diseases, autoimmune disorders, etc., that may influence cellular/healing status
Diabetics
Current smokers
Individual less than 18 years of age
Individuals with non-isolated, interproximal PD ≥ 4 mm extending to the facial/buccal and/or palatal/lingual tooth surfaces
Teeth with Grade 2 or 3 mobility
Teeth with metal restorations such as a porcelain fused to metal crown (due to scattering of radiographic images)
Intrabony defects on dental implants
Individual who take medications known to affect host immunity or periodontal tissues (ex. steroids, antibiotics, phenytoin, etc.) in the previous 6 months
Individuals on chronic anti-platelet/anti-coagulant therapy
Oral pathologies other than periodontal disease (ex. periapical lesions of non-periodontal origin)
Subjects who may be pregnant based on a positive pregnancy test
Non-English speaking individuals

What this trial measures

  • Clinical Attachment Level6 months

    Measured in mm as the periodontal probing depth (PD) plus gingival recession (GR).

  • Probing Depth (PD)6 months

    Measured in mm as the distance from the gingival margin (GM) to the base of the gingival sulcus.

  • Gingival Recession (GR)6 months

    Measured in mm as distance of the gingival margin (GM) to the cemento-enamel junction (CEJ).

  • Radiographic Bone Height (RBH)6 months

    Measured in mm as the distance from the cemento-enamel junction (CEJ) to the base of the alveolar bone defect (ABD).

  • Radiographic Bone Volume (RBV)6 months

    Measured in cubic mm as the volume of bone from the alveolar crest (AC) to the base of the alveolar bone defect (ABD).

  • Clinical Attachment Level12 months

    Measured in mm as the periodontal probing depth (PD) plus gingival recession (GR).

  • Probing Depth (PD)12 months

    Measured in mm as the distance from the gingival margin (GM) to the base of the gingival sulcus.

  • Gingival Recession (GR)12 months

    Measured in mm as distance of the gingival margin (GM) to the cemento-enamel junction (CEJ).

  • Radiographic Bone Height (RBH)12 months

    Measured in mm as the distance from the cemento-enamel junction (CEJ) to the base of the alveolar bone defect (ABD).

  • Radiographic Bone Volume (RBV)12 months

    Measured in cubic mm as the volume of bone from the alveolar crest (AC) to the base of the alveolar bone defect (ABD).